HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 274 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,313,453 | +103704.9% | 86,740 | +38.7% | 0.02% | -32.0% |
Q4 2022 | $3,192 | -99.9% | 62,557 | -3.0% | 0.02% | 0.0% |
Q3 2022 | $3,005,000 | -5.0% | 64,525 | +2.1% | 0.02% | -3.8% |
Q2 2022 | $3,164,000 | +12.8% | 63,192 | -2.5% | 0.03% | +30.0% |
Q1 2022 | $2,806,000 | -3.9% | 64,802 | -25.6% | 0.02% | -4.8% |
Q4 2021 | $2,921,000 | -15.7% | 87,123 | -2.3% | 0.02% | 0.0% |
Q3 2021 | $3,464,000 | -10.1% | 89,133 | -11.1% | 0.02% | -8.7% |
Q2 2021 | $3,855,000 | -25.2% | 100,222 | -1.9% | 0.02% | -25.8% |
Q1 2021 | $5,157,000 | -0.6% | 102,204 | -2.5% | 0.03% | -6.1% |
Q4 2020 | $5,187,000 | +357.8% | 104,798 | +187.7% | 0.03% | +312.5% |
Q3 2020 | $1,133,000 | -0.7% | 36,423 | -11.2% | 0.01% | -11.1% |
Q2 2020 | $1,141,000 | +20.0% | 41,034 | +1.0% | 0.01% | 0.0% |
Q1 2020 | $951,000 | – | 40,615 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |